Tadagra Softgel 20 Mg belongs to a class of medications known as phosphodiesterase type 5 (PDE5) inhibitors, primarily used to treat erectile dysfunction. However, recent research has explored its potential application in ophthalmology due to its vasodilatory properties. By inhibiting PDE5, Tadagra Softgel 20 Mg promotes the relaxation of blood vessels, thereby improving blood flow to ocular tissues. This mechanism may have implications for various ophthalmic disorders characterized by compromised blood circulation or vascular dysfunction. Ophthalmic disorders encompass a spectrum of conditions affecting the eyes, with cataracts, glaucoma, AMD, and diabetic retinopathy among the most prevalent. These disorders can lead to vision impairment and even blindness if left untreated, underscoring the importance of effective interventions. While current treatment approaches vary depending on the specific condition, they often involve surgery, medication, or a combination thereof.